[up] Up a level
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.

Article

Moss, DM, Liptrott, NJ, Curley, P, Siccardi, M, Back, DJ and Owen, A (2013) Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro. Antimicrobial Agents and Chemotherapy, 57 (11). pp. 5612-5618.

Moss, DM, Siccardi, M, Back, DJ and Owen, A (2013) Predicting intestinal absorption of raltegravir using a population-based ADME simulation. Journal of Antimicrobial Chemotherapy, 68 (7). pp. 1627-1634.

Moss, DM, Siccardi, M, Murphy, M, Piperakis, MM, Khoo, SH, Back, DJ and Owen, A (2012) Divalent metals and pH alter raltegravir disposition in vitro. Antimicrobial Agents and Chemotherapy, 56 (6). pp. 3020-3026.

Moss, DM, Kwan, WS, Liptrott, NJ, Smith, DL, Siccardi, M, Khoo, SH, Back, DJ and Owen, A (2011) Raltegravir is a substrate for SLC22A6: A putative mechanism for the interaction between raltegravir and tenofovir. Antimicrobial Agents and Chemotherapy, 55 (2). pp. 879-887.

This list was generated on Wed Nov 1 00:01:18 2023 UTC.